The Claim
Selenium nanoparticles of 40.4 nm size, administered at 50 μg Se/kg/day for 24 weeks to apolipoprotein E-deficient mice on a high-fat diet, are associated with greater increases in atherosclerotic lesions and oxidative stress compared to selenium nanoparticles of 23.1 nm or 86.8 nm size under the same conditions.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice genetically predisposed to atherosclerosis and fed a high-fat diet, selenium nanoparticles of 40.4 nanometers caused larger increases in arterial plaque and oxidative stress markers than nanoparticles of 23.1 or 86.8 nanometers when given at the same dose for the same duration.
See the scientific wording
Selenium nanoparticles of 40.4 nm size, administered at 50 μg Se/kg/day for 24 weeks to apolipoprotein E-deficient mice on a high-fat diet, are associated with greater increases in atherosclerotic lesions and oxidative stress compared to 23.1 nm or 86.8 nm nanoparticles.
Selenium nanoparticles of 40.4 nm size enter the body more efficiently than other sizes, settle in the liver and blood vessels, block natural antioxidant enzymes, cause a buildup of harmful molecules that damage fats and cells, and disrupt the liver's ability to manage fats. This leads to more fat in the blood and more damage to artery walls, making plaques grow larger and become more unstable.
What the research says
1 studyIn mice prone to heart disease, scientists gave three different sizes of selenium nanoparticles for six months. The 40.4 nm ones made the arteries worse and caused more cell damage than the smaller or larger ones.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.